Compare PIII & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PIII | YI |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8M | 29.2M |
| IPO Year | 2021 | 2018 |
| Metric | PIII | YI |
|---|---|---|
| Price | $9.49 | $3.33 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 34.0K | 5.9K |
| Earning Date | 05-14-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,459,080,000.00 | N/A |
| Revenue This Year | $7.67 | N/A |
| Revenue Next Year | $2.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.52 | $2.48 |
| 52 Week High | $16.89 | $11.17 |
| Indicator | PIII | YI |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 40.70 |
| Support Level | $9.00 | $2.48 |
| Resistance Level | $11.55 | $4.01 |
| Average True Range (ATR) | 0.58 | 0.22 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 34.26 | 40.16 |
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.